Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
Status: Enrolling
Updated:  7/6/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
Status: Enrolling
Updated: 7/6/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
Maricopa Integrated Health System
mi
from
Phoenix, AZ
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
Maricopa Integrated Health System
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
Los Angeles County-USC Medical Center
mi
from
Los Angeles, CA
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
Los Angeles County-USC Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
UC Davis Medical Center
mi
from
Sacramento, CA
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
UC Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
Stanford University
mi
from
Stanford, CA
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
Yale University
mi
from
New Haven, CT
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
Northwestern University
mi
from
Chicago, IL
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
West Suburban Hospital Medical Center
mi
from
Oak Park, IL
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
West Suburban Hospital Medical Center
mi
from
Oak Park, IL
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
Illinois Lung and Critical Care Institute
mi
from
Peoria, IL
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
Illinois Lung and Critical Care Institute
mi
from
Peoria, IL
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
University of Iowa
mi
from
Iowa City, IA
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
Kentucky Lung Clinic
mi
from
Hazard, KY
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
Kentucky Lung Clinic
mi
from
Hazard, KY
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
University of Louisville-Division of Pulmonary and Critical Care
mi
from
Louisville, KY
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
University of Louisville-Division of Pulmonary and Critical Care
mi
from
Louisville, KY
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
Baystate Medical Center
mi
from
Springfield, MA
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
Baystate Medical Center
mi
from
Springfield, MA
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
Saint Luke's Hospital
mi
from
Chesterfield, MO
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
Saint Luke's Hospital
mi
from
Chesterfield, MO
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
St. John's Mercy Medical Center
mi
from
St. Louis, MO
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
St. John's Mercy Medical Center
mi
from
St. Louis, MO
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
Saint Louis University
mi
from
St. Louis, MO
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
Saint Louis University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
Mount Sinai Hospital
mi
from
New York, NY
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
Carolinas Medical Center
mi
from
Charlotte, NC
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
Piedmont Respiratory Research Foundation
mi
from
Greensboro, NC
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
Piedmont Respiratory Research Foundation
mi
from
Greensboro, NC
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
Wake Forest University
mi
from
Charlotte, NC
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
Wake Forest University
mi
from
Charlotte, NC
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
University of Oklahoma
mi
from
Oklahoma City, OK
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  7/11/2012
Baylor College of Medicine
mi
from
Houston, TX
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 7/11/2012
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Clinical Evaluation of a Closed Loop Oxygen Controller for Neonatal Respiratory Care
Clinical Evaluation of a Closed Loop Oxygen Controller for Neonatal Respiratory Care
Status: Enrolling
Updated:  7/11/2012
University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Clinical Evaluation of a Closed Loop Oxygen Controller for Neonatal Respiratory Care
Clinical Evaluation of a Closed Loop Oxygen Controller for Neonatal Respiratory Care
Status: Enrolling
Updated: 7/11/2012
University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Clinical Evaluation of a Closed Loop Oxygen Controller for Neonatal Respiratory Care
Clinical Evaluation of a Closed Loop Oxygen Controller for Neonatal Respiratory Care
Status: Enrolling
Updated:  7/11/2012
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Clinical Evaluation of a Closed Loop Oxygen Controller for Neonatal Respiratory Care
Clinical Evaluation of a Closed Loop Oxygen Controller for Neonatal Respiratory Care
Status: Enrolling
Updated: 7/11/2012
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Continous Positive Airway Pressure (CPAP) Compliance Study
ICAN (Improvement in CPAP Adherence Via the Net) Study
Status: Enrolling
Updated:  7/16/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Continous Positive Airway Pressure (CPAP) Compliance Study
ICAN (Improvement in CPAP Adherence Via the Net) Study
Status: Enrolling
Updated: 7/16/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Sunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed Tomography
Inspiratory Capacity and HRCT Comparison of Nebulized Arformoterol (Brovana) vs. Dry-powder Inhaler Salmeterol (Serevent)
Status: Enrolling
Updated:  7/18/2012
UCLA
mi
from
Los Angeles, CA
Sunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed Tomography
Inspiratory Capacity and HRCT Comparison of Nebulized Arformoterol (Brovana) vs. Dry-powder Inhaler Salmeterol (Serevent)
Status: Enrolling
Updated: 7/18/2012
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
Status: Enrolling
Updated:  7/25/2012
Michael E. DeBakey Veterans Affairs Medical Center
mi
from
Houston, TX
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
Status: Enrolling
Updated: 7/25/2012
Michael E. DeBakey Veterans Affairs Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Pramipexole as a Treatment for Cocaine Dependence
Pramipexole as a Treatment for Cocaine Dependence
Status: Enrolling
Updated:  7/25/2012
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Pramipexole as a Treatment for Cocaine Dependence
Pramipexole as a Treatment for Cocaine Dependence
Status: Enrolling
Updated: 7/25/2012
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Sildenafil Trial in Children and Young Adults With CF
Randomized Controlled Study of Sildenafil in Children and Young Adults With Mild to Moderate Cystic Fibrosis Lung Disease
Status: Enrolling
Updated:  8/2/2012
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Sildenafil Trial in Children and Young Adults With CF
Randomized Controlled Study of Sildenafil in Children and Young Adults With Mild to Moderate Cystic Fibrosis Lung Disease
Status: Enrolling
Updated: 8/2/2012
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Progesterone for Postpartum Cocaine Relapse
Progesterone for Postpartum Cocaine Relapse
Status: Enrolling
Updated:  8/7/2012
Yale School of Medicine
mi
from
New Haven, CT
Progesterone for Postpartum Cocaine Relapse
Progesterone for Postpartum Cocaine Relapse
Status: Enrolling
Updated: 8/7/2012
Yale School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
BRIPPED Scan for Evaluation of Emergency Department (ED) Patients With Shortness of Breath
BRIPPED Scan for Evaluation of Emergency Department Patients With Shortness of Breath
Status: Enrolling
Updated:  8/9/2012
Sentara Norfolk General Emergency Department
mi
from
Norfolk, VA
BRIPPED Scan for Evaluation of Emergency Department (ED) Patients With Shortness of Breath
BRIPPED Scan for Evaluation of Emergency Department Patients With Shortness of Breath
Status: Enrolling
Updated: 8/9/2012
Sentara Norfolk General Emergency Department
mi
from
Norfolk, VA
Click here to add this to my saved trials
Continuous Positive Airway Pressure (CPAP) for Fatigue in Patients With Multiple Sclerosis (MS) and Obstructive Sleep Apnea (OSA)
Continuous Positive Airway Pressure for Fatigue Treatment in Patients With Multiple Sclerosis and Obstructive Sleep Apnea
Status: Enrolling
Updated:  8/20/2012
Northwestern UNiversity, Department of Neurology
mi
from
Chicago, IL
Continuous Positive Airway Pressure (CPAP) for Fatigue in Patients With Multiple Sclerosis (MS) and Obstructive Sleep Apnea (OSA)
Continuous Positive Airway Pressure for Fatigue Treatment in Patients With Multiple Sclerosis and Obstructive Sleep Apnea
Status: Enrolling
Updated: 8/20/2012
Northwestern UNiversity, Department of Neurology
mi
from
Chicago, IL
Click here to add this to my saved trials
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated:  8/21/2012
Concentrics Center for Research
mi
from
Indianapolis, IN
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated: 8/21/2012
Concentrics Center for Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated:  8/21/2012
Cyn3rgy Research
mi
from
Gresham, OR
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated: 8/21/2012
Cyn3rgy Research
mi
from
Gresham, OR
Click here to add this to my saved trials
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated:  8/21/2012
DMI Research
mi
from
Pinellas, FL
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated: 8/21/2012
DMI Research
mi
from
Pinellas, FL
Click here to add this to my saved trials
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated:  8/21/2012
Clinical Research Associates Incorporated
mi
from
Nashville, TN
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated: 8/21/2012
Clinical Research Associates Incorporated
mi
from
Nashville, TN
Click here to add this to my saved trials
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence
Status: Enrolling
Updated:  9/6/2012
Veteran's Affairs Medical Center
mi
from
Denver, CO
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence
Status: Enrolling
Updated: 9/6/2012
Veteran's Affairs Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa (PA) in the Lower Airways
Status: Enrolling
Updated:  9/7/2012
Children's Hospital Denver
mi
from
Aurora, CO
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa (PA) in the Lower Airways
Status: Enrolling
Updated: 9/7/2012
Children's Hospital Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa (PA) in the Lower Airways
Status: Enrolling
Updated:  9/7/2012
Nemours Children's Clinic
mi
from
Jacksonville, FL
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa (PA) in the Lower Airways
Status: Enrolling
Updated: 9/7/2012
Nemours Children's Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa (PA) in the Lower Airways
Status: Enrolling
Updated:  9/7/2012
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa (PA) in the Lower Airways
Status: Enrolling
Updated: 9/7/2012
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa (PA) in the Lower Airways
Status: Enrolling
Updated:  9/7/2012
Riley Hospital for Children
mi
from
Indianapolis, IN
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa (PA) in the Lower Airways
Status: Enrolling
Updated: 9/7/2012
Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa (PA) in the Lower Airways
Status: Enrolling
Updated:  9/7/2012
Children's Hospital - Boston
mi
from
Boston, MA
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa (PA) in the Lower Airways
Status: Enrolling
Updated: 9/7/2012
Children's Hospital - Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa (PA) in the Lower Airways
Status: Enrolling
Updated:  9/7/2012
Children's Mercy Hospital and Clinics
mi
from
Kansas City, MO
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa (PA) in the Lower Airways
Status: Enrolling
Updated: 9/7/2012
Children's Mercy Hospital and Clinics
mi
from
Kansas City, MO
Click here to add this to my saved trials
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa (PA) in the Lower Airways
Status: Enrolling
Updated:  9/7/2012
SUNY Upstate Medical University Hospital
mi
from
Syracuse, NY
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa (PA) in the Lower Airways
Status: Enrolling
Updated: 9/7/2012
SUNY Upstate Medical University Hospital
mi
from
Syracuse, NY
Click here to add this to my saved trials
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa (PA) in the Lower Airways
Status: Enrolling
Updated:  9/7/2012
Nationwide Children's Hospital
mi
from
Columbus, OH
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa (PA) in the Lower Airways
Status: Enrolling
Updated: 9/7/2012
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa (PA) in the Lower Airways
Status: Enrolling
Updated:  9/7/2012
Baylor College of Medicine
mi
from
Houston, TX
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa (PA) in the Lower Airways
Status: Enrolling
Updated: 9/7/2012
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa (PA) in the Lower Airways
Status: Enrolling
Updated:  9/7/2012
University of Utah
mi
from
Salt Lake City, UT
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa (PA) in the Lower Airways
Status: Enrolling
Updated: 9/7/2012
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence
Open-Label Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence
Status: Enrolling
Updated:  9/18/2012
Univ of Minnesota
mi
from
Minneapolis, MN
Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence
Open-Label Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence
Status: Enrolling
Updated: 9/18/2012
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Continuous Infusion Piperacillin-tazobactam for the Treatment of Cystic Fibrosis
Continuous Infusion Piperacillin-Tazobactam for the Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  9/24/2012
West Virginia University Healthcare
mi
from
Morgantown, WV
Continuous Infusion Piperacillin-tazobactam for the Treatment of Cystic Fibrosis
Continuous Infusion Piperacillin-Tazobactam for the Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 9/24/2012
West Virginia University Healthcare
mi
from
Morgantown, WV
Click here to add this to my saved trials